Staley Capital Advisers Inc Pfizer Inc Transaction History

Staley Capital Advisers Inc

$2.12 Billion
Q1 2024

A detailed history of Staley Capital Advisers Inc transactions in Pfizer Inc stock. As of the latest transaction made, Staley Capital Advisers Inc holds 1,500,246 shares of PFE stock, worth $42 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares

1,500,246

Previous 1,304,550 15.0%

Holding current value

$42 Million

Previous $37.6 Million 10.85%

% of portfolio

1.97%

Previous 1.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $5.07 Million - $5.82 Million	195,696 Added 15.0%	1,500,246 $41.6 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $1.09 Million - $1.41 Million	-41,637 Reduced 3.09%	1,304,550 $37.6 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.77 Million - $2.07 Million	55,290 Added 4.28%	1,346,187 $44.7 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $1.81 Million - $2.1 Million	50,173 Added 4.04%	1,290,897 $47.4 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $1.99 Million - $2.58 Million	50,407 Added 4.23%	1,240,724 $50.6 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $409,985 - $535,190	-9,820 Reduced 0.82%	1,190,317 $61 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $699,984 - $854,506	-15,996 Reduced 1.32%	1,200,137 $52.5 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $158,062 - $187,412	-3,397 Reduced 0.28%	1,216,133 $63.8 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $315,720 - $391,217	6,901 Added 0.57%	1,219,530 $63.1 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $1.57 Million - $2.33 Million	-37,965 Reduced 3.04%	1,212,629 $71.6 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $295,160 - $379,158	-7,520 Reduced 0.6%	1,250,594 $53.8 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $1.35 Million - $1.53 Million	37,575 Added 3.08%	1,258,114 $49.3 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $2.8 Million - $3.16 Million	83,737 Added 7.37%	1,220,539 $44.2 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $123,738 - $157,344	-3,697 Reduced 0.32%	1,136,802 $41.8 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $501,713 - $588,624	-15,802 Reduced 1.37%	1,140,499 $41.9 Million
Q2 2020 Aug 18, 2020	SELL	$30.12 - $36.54 $60,240 - $73,080	-2,000 Reduced 0.17%	1,156,301 $37.8 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $3.03 Million - $3.68 Million	-100,599 Reduced 7.99%	1,158,301 $37.9 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $1.42 Million - $2.03 Million	52,507 Added 4.35%	1,258,900 $41.1 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $581,498 - $659,927	17,664 Added 1.49%	1,206,393 $47.3 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $3.09 Million - $4.01 Million	95,155 Added 8.7%	1,188,729 $42.7 Million
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $747,957 - $839,783	20,226 Added 1.88%	1,093,574 $47.4 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $320,325 - $351,930	8,542 Added 0.8%	1,073,348 $45.6 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $1.85 Million - $2.11 Million	-48,031 Reduced 4.32%	1,064,806 $46.5 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $122,023 - $148,007	3,540 Added 0.32%	1,112,837 $49 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $84,758 - $90,361	-2,570 Reduced 0.23%	1,109,297 $40.2 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $2.73 Million - $3.17 Million	85,665 Added 8.35%	1,111,867 $39.5 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $183,927 - $195,153	5,530 Added 0.54%	1,026,202 $37.2 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $52,793 - $58,157	1,703 Added 0.17%	1,020,672 $36.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,018,969	1,018,969 $34.2 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.

Account

Staley Capital Advisers Inc Pfizer Inc Transaction History